Results 351 to 360 of about 463,657 (378)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours

Nature Genetics, 1996
R. Souza, Rebecca Appel, Jingyu Yin, Suna Wang, K. Smolinski, J. Abraham, T. Zou, Y. Shi, J. Lei, John Cottrell, K. Cymes, K. Biden, L. Simms, B. Leggett, P. Lynch, M. Frazier, S. Powell, Noam Harpas, H. Sugimura, Joanne P. Young, S. Meltzer   +20 more
semanticscholar   +1 more source

Insulin‐like growth factors I and II

European Journal of Biochemistry, 1990
openaire   +2 more sources

A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis

Nature, 1994
G. Christofori, P. Naik, D. Hanahan
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Insulin‐like growth factor‐II: its role in metabolic and endocrine disease

Clinical Endocrinology, 2014
C. Livingstone, A. Borai
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Ca-A Cancer Journal for Clinicians, 2018
Farhad Islami, Ann Goding Sauer, Kimberly D Miller   +2 more
exaly